Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

PINCH-1 is crucial for skin cell adhesion and movement, working with EPLIN and ILK.

Cellcurex™ treatment increased hair growth and thickness but caused pain and bleeding.

Cepharanthine could be a strong antiviral against COVID-19.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

The research found a way to develop hair growth materials by targeting a specific signaling pathway.

A new compound shows promise as a topical treatment for hair loss.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Topical ruxolitinib quickly improves non-segmental vitiligo.

The formulated gel is a promising treatment for alopecia areata.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

The formula significantly boosts hair growth and density.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Tadalafil and Finasteride may help treat aggressive melanoma.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.